IRIS
FERRARI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.175
AS - Asia 8.794
EU - Europa 4.943
SA - Sud America 1.200
AF - Africa 467
Continente sconosciuto - Info sul continente non disponibili 370
OC - Oceania 27
Totale 24.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.920
SG - Singapore 3.072
CN - Cina 2.243
VN - Vietnam 1.251
IT - Italia 1.099
IE - Irlanda 935
BR - Brasile 924
SE - Svezia 710
HK - Hong Kong 650
BD - Bangladesh 546
DE - Germania 493
FI - Finlandia 399
FR - Francia 395
TR - Turchia 385
ZA - Sudafrica 328
NL - Olanda 278
CA - Canada 151
IN - India 137
GB - Regno Unito 126
UA - Ucraina 106
AR - Argentina 97
RU - Federazione Russa 97
JP - Giappone 78
IQ - Iraq 64
KR - Corea 55
MX - Messico 53
CI - Costa d'Avorio 43
EC - Ecuador 42
PK - Pakistan 40
PL - Polonia 40
AT - Austria 38
BE - Belgio 37
VE - Venezuela 37
ID - Indonesia 36
CO - Colombia 35
PH - Filippine 35
ES - Italia 34
TH - Thailandia 31
DK - Danimarca 29
UZ - Uzbekistan 27
MA - Marocco 23
AU - Australia 22
LT - Lituania 22
KE - Kenya 21
RO - Romania 20
TW - Taiwan 20
PY - Paraguay 17
CZ - Repubblica Ceca 16
EG - Egitto 14
SA - Arabia Saudita 14
CL - Cile 13
UY - Uruguay 13
OM - Oman 11
BO - Bolivia 10
JO - Giordania 10
PE - Perù 10
AZ - Azerbaigian 9
IL - Israele 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
CH - Svizzera 8
GR - Grecia 8
KZ - Kazakistan 8
TN - Tunisia 8
IR - Iran 7
LV - Lettonia 7
PA - Panama 7
CR - Costa Rica 6
PT - Portogallo 6
AL - Albania 5
BY - Bielorussia 5
EU - Europa 5
HN - Honduras 5
JM - Giamaica 5
NI - Nicaragua 5
NP - Nepal 5
RS - Serbia 5
BB - Barbados 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
LU - Lussemburgo 3
NG - Nigeria 3
SN - Senegal 3
TG - Togo 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
GA - Gabon 2
Totale 24.572
Salva come PNG Salva come JPEG
Città #
Singapore 1.455
Ashburn 1.087
San Jose 1.057
Dublin 934
Chandler 729
Santa Clara 652
Hong Kong 623
Dallas 527
Beijing 460
Dearborn 409
Ho Chi Minh City 377
Council Bluffs 339
Johannesburg 307
Izmir 300
Boardman 298
Hanoi 296
Nanjing 250
New York 227
Parma 201
Princeton 200
Los Angeles 197
Munich 196
Lauterbourg 195
Shanghai 158
Ann Arbor 155
Wilmington 153
Helsinki 134
Milan 113
Jacksonville 109
Columbus 107
São Paulo 95
Rome 89
Buffalo 81
Shenyang 77
Hebei 74
Hefei 65
Nanchang 64
Moscow 62
Chicago 60
Tianjin 59
Tokyo 58
Toronto 58
Da Nang 57
Haiphong 55
Kunming 54
Seattle 54
Jinan 51
The Dalles 50
Guangzhou 47
Düsseldorf 44
Abidjan 43
Grafing 42
Jiaxing 42
Rio de Janeiro 42
Changsha 41
Bremen 40
Frankfurt am Main 39
Houston 39
Kocaeli 39
Montreal 39
Bologna 38
San Mateo 37
London 35
Stockholm 35
Norwalk 34
Des Moines 33
Brussels 32
Nuremberg 31
Zhengzhou 30
Warsaw 29
Turku 28
Hải Dương 27
Phoenix 27
Brooklyn 26
Seoul 26
Vienna 26
Marseille 25
Tashkent 25
Baghdad 24
Taastrup 23
Belo Horizonte 22
Hangzhou 22
Curitiba 21
Mestre 21
Orem 21
Atlanta 20
Charlotte 20
Denver 19
Jakarta 19
San Francisco 19
Brasília 18
Mexico City 18
Naples 18
Pune 18
Bengaluru 17
Boston 17
Reggio Emilia 17
Washington 17
Can Tho 16
Ardea 15
Totale 14.871
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 329
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 324
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 292
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 284
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 214
A simplified sars-cov-2 pseudovirus neutralization assay 213
The anti-COVID-19 vaccine unveils latent systemic sclerosis 208
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 208
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 208
Therapeutic potential of co-signaling receptor modulation in hepatitis B 197
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 188
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study 188
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 187
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 184
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 183
Metabolic regulation of the HBV-specific T cell function 180
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 178
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients 177
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 172
ALTERAZIONI DELLA FUNZIONALITA’ TIROIDEA IN PAZIENTI AFFETTI DA EPATITE CRONICA ATTIVA DA VIRUS C IN TERAPIA CON INTERFERONE E RIBAVIRINA E CORRELAZIONE CON LA RISPOSTA ALLA TERAPIA ANTIVIRALE 163
Practice of proctology among general surgery residents and young specialists in Italy: a snapshot survey 162
Alterazioni della funzionalità tiroidea in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone e ribavirina e correlazione con la risposta alla terapia antivirale. 161
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 159
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 159
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 158
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 156
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 155
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 153
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 152
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 151
Adaptive immunity in HBV infection 151
HBV immune-therapy: From molecular mechanisms to clinical applications 150
Le linee di ricerca strategiche di un'azienda ospedaliero-universitaria: proposta di un metodo qualiquantitativo 149
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 148
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J. Hepatol. 146
T cell regulation in HBV-related chronic liver disease 146
[An outbreak type A hepatitis in a family group living in a village near Parma. Epidemiologic evaluation and prophylaxis (author's transl)] 145
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 144
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 143
Tiroiditi distruttive in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone: nostra esperienza 143
RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection 143
STUDIO E COMPARAZIONE DELLE ALTERAZIONI DI FUNZIONALITA’ TIROIDEA INDOTTE DA INTERFERONE NEI SOGGETTI CON EPATITE CRONICA ATTIVA DA VIRUS C RISPETTO A SOGGETTI DI CONTROLLO 142
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV 142
Course of Graves' disease in interferon-treated patients with chronic hepatitis C virus infection and in uninfected patients 141
COMPOSTO FARMACEUTICO PER L’USO IN UN TRATTAMENTO TERAPEUTICO DELL’INFEZIONE CRONICA DA HBV E METODO PER L’IDENTIFICAZIONE DI LINFOCITI ESAURITI 138
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 137
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 137
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group 136
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection 133
[Non-A, non-B hepatitis. Seroimmunological, epidemiological and clinical findings] 132
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection 132
[The cell-mediated antiviral immune response. The possible therapeutic implications for chronic hepatitis B viral infection] 129
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 128
[Infectious agents in the G.I. tract diseases (author's transl)] 127
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection 127
Clinical spectrum of cryoglobulinaemic neuropathy 126
A global scientific strategy to cure hepatitis B 126
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 125
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 123
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 122
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 122
Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study 121
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 120
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 120
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probably related to integrase inhibitor use 120
New perspectives for T-cell-based HCV vaccines 119
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 119
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 119
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 119
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 118
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B 117
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 117
Clinical features of hepatitis delta virus infection in a northern Italian area 116
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 116
[The immunopathogenesis of hepatitis B] 115
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 115
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 115
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection 115
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 115
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C? 114
Fine specificity of the human T cell response to hepatitis B virus core antigen 114
Graves Disease In Interferon - Treated and Untreated Patients with Chronic Hepatitis C Virus Infection 113
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines 113
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 111
Comparative pathogenesis of HBV and HCV 110
Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma, Emilia-Romagna region, Italy 110
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 110
[Hepatitis B virus infection in a hospital population in Parma: implementation of a vaccination program] 109
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 108
Immune pathogenesis of hepatitis B 108
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 108
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 108
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. 108
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 107
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 106
T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail 105
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study 105
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 105
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 105
Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis 105
Totale 14.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022793 0 17 7 48 74 58 47 88 48 26 30 350
2022/20233.180 406 247 168 205 222 361 43 188 1.126 16 142 56
2023/20241.476 82 144 61 76 121 350 92 120 59 89 91 191
2024/20254.869 104 271 290 244 543 595 235 225 660 422 389 891
2025/202610.465 859 1.072 1.102 765 1.303 504 1.067 327 1.386 760 769 551
2026/2027672 282 390 0 0 0 0 0 0 0 0 0 0
Totale 24.976